EGFR and cancer: In this regard, our previous data indicated that HBP inhibition, achieved through cancer cell treatment with the FR054, causes the decrease in the integrin membrane localization, cell adhesion, and migration, as well as the inhibition of the EGFR and Akt signaling [15].